Published on 2 Nov 2023 on Exec Edge via Yahoo Finance
By Daniella Parra
Eterna Therapeutics Inc. (Nasdaq: ERNA) said it appointed Dr. James Bristol, an experienced biopharmaceutical executive with a background in research and drug discovery, to its Board of Directors.